The Happy Pod: Personalised cancer vaccine shows promise in major trial

A new personalised skin cancer vaccine has been found to reduce the risk of patients dying or their cancer returning by 42%. As part of a global two-year clinical trial, more than 1,000 patients who had already had their tumours removed were given a widely used immunotherapy drug. Around two-thirds were then given the experimental vaccine, which was developed using cells from their own tumours. Researchers say the results could mark a turning point in cancer treatment. Also: How a man achieved h